RON HOOGEVEEN's research topics

RON HOOGEVEEN

Concepts (303)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with RON HOOGEVEEN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that RON HOOGEVEEN has written about over time.

Cholesterol, 6 publications between 2002 and 2018, average publication date June 2010. 1-Alkyl-2-acetylglycerophosphocholine Esterase, 8 publications between 2004 and 2019, average publication date March 2011. Triglycerides, 7 publications between 2002 and 2022, average publication date May 2012. Coronary Disease, 13 publications between 2003 and 2023, average publication date September 2012. C-Reactive Protein, 10 publications between 2004 and 2023, average publication date July 2013. Cholesterol, LDL, 12 publications between 2003 and 2022, average publication date January 2014. Lipoproteins, 8 publications between 2002 and 2022, average publication date July 2014. Apolipoprotein C-III, 3 publications between 2006 and 2022, average publication date November 2014. Stroke, 10 publications between 2005 and 2023, average publication date January 2015. Biomarkers, 36 publications between 2004 and 2024, average publication date January 2015. Brain Ischemia, 4 publications between 2005 and 2023, average publication date March 2015. Cardiovascular Diseases, 17 publications between 2005 and 2023, average publication date November 2015. Troponin T, 13 publications between 2013 and 2024, average publication date May 2016. Atherosclerosis, 24 publications between 2005 and 2023, average publication date October 2016. Prediabetic State, 2 publications between 2014 and 2018, average publication date October 2016. Diabetes Mellitus, 4 publications between 2014 and 2022, average publication date October 2017. Apolipoproteins E, 2 publications between 2017 and 2018, average publication date March 2018. Lipoprotein(a), 7 publications between 2011 and 2022, average publication date April 2018. Heart Failure, 11 publications between 2013 and 2023, average publication date January 2019. Hypolipidemic Agents, 1 publications between 2021 and 2021, average publication date January 2021.

Cholesterol
1-Alkyl-2-acetylglycerophosphocholine Esterase
Triglycerides
Coronary Disease
C-Reactive Protein
Cholesterol, LDL
Lipoproteins
Apolipoprotein C-III
Stroke
Biomarkers
Brain Ischemia
Cardiovascular Diseases
Troponin T
Atherosclerosis
Prediabetic State
Diabetes Mellitus
Apolipoproteins E
Lipoprotein(a)
Heart Failure
Hypolipidemic Agents

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Cholesterol	6	2002	2018	June 2010
1-Alkyl-2-acetylglycerophosphocholine Esterase	8	2004	2019	March 2011
Triglycerides	7	2002	2022	May 2012
Coronary Disease	13	2003	2023	September 2012
C-Reactive Protein	10	2004	2023	July 2013
Cholesterol, LDL	12	2003	2022	January 2014
Lipoproteins	8	2002	2022	July 2014
Apolipoprotein C-III	3	2006	2022	November 2014
Stroke	10	2005	2023	January 2015
Biomarkers	36	2004	2024	January 2015
Brain Ischemia	4	2005	2023	March 2015
Cardiovascular Diseases	17	2005	2023	November 2015
Troponin T	13	2013	2024	May 2016
Atherosclerosis	24	2005	2023	October 2016
Prediabetic State	2	2014	2018	October 2016
Diabetes Mellitus	4	2014	2022	October 2017
Apolipoproteins E	2	2017	2018	March 2018
Lipoprotein(a)	7	2011	2022	April 2018
Heart Failure	11	2013	2023	January 2019
Hypolipidemic Agents	1	2021	2021	January 2021

HOOGEVEEN's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (303)

Explore

Co-Authors (30)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors